会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 30. 发明授权
    • Inhibition of vascular smooth muscle cell proliferation with implanted
matrix containing vascular endothelial cells
    • 用含有血管内皮细胞的植入基质抑制血管平滑肌细胞增殖
    • US5766584A
    • 1998-06-16
    • US458978
    • 1995-06-02
    • Elazer R. EdelmanAruna NathanMatthew A. Nugent
    • Elazer R. EdelmanAruna NathanMatthew A. Nugent
    • A61L27/00A61K35/12A61L27/50A61L31/00C12N5/071C12N11/00C12N11/08C12N5/00
    • C12N5/069A61L27/507A61L31/005A61K35/12C12N2533/54
    • A composition and method are provided for inhibition of vascular smooth muscle cell proliferation following injury to the endothelial cell lining of a blood vessel such as resulting from angioplasty, vascular bypass surgery or organ transplantation. The composition is a matrix such as a biodegradable hydrogel made of a synthetic polymer, protein or polysaccharide seeded with vascular endothelial cells which can be xenografts, allografts or autografts, or genetically engineered cells. Attachment of cells to the matrix can be enhanced by coating with collagen, laminin, fibronectin, fibrin, basement membrane components or attachment peptides. Biologically active compounds such as anti-inflammatory agents may also be contained in the matrix. In the method, the matrix containing endothelial cells is implanted in a patient at a site adjacent the injury such as by wrapping the matrix around the blood vessel. The endothelial cells secrete products that diffuse into surrounding tissue but do not migrate to the endothelial cell lining of the blood vessel. The endothelial cells may be obtained by biopsy of the patient into which the matrix is implanted and the cells can be cultured in the matrix in vitro and then implanted in vivo.
    • 提供了一种组合物和方法,用于在血管成形术,血管旁路手术或器官移植导致的血管内皮细胞内膜损伤后抑制血管平滑肌细胞增殖。 该组合物是一种基质,例如由可以是异种移植物,同种异体移植物或自体移植物或基因工程细胞的合成聚合物,蛋白质或多糖接种的血管内皮细胞制成的可生物降解的水凝胶。 可以通过用胶原,层粘连蛋白,纤连蛋白,纤维蛋白,基底膜组分或附着肽进行包被来增强细胞对基质的附着。 生物活性化合物如抗炎剂也可以包含在基质中。 在该方法中,将包含内皮细胞的基质植入患者附近的部位,例如通过将基质缠绕在血管周围。 内皮细胞分泌扩散到周围组织中的产物,但不迁移到血管的内皮细胞衬里。 内皮细胞可以通过移植基质的患者的活组织检查获得,并且细胞可以在体外在基质中培养,然后在体内植入。